Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PfSPZ Vaccine in Tanzanian Adults
NCT02132299Phase 1Completed
- Sponsor
- Sanaria Inc.
- Start
- Apr 2014
- Primary completion
- Jul 2015
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of Sanaria PfSPZ Vaccine in Plasmodium falciparum malaria (7 arms), sponsored by Sanaria Inc. Primary endpoints: Safety and tolerability endpoints and Protective Efficacy after CHMI with PfSPZ Challenge. Started Apr 2014; status: completed.
02
Drugs
Sanaria PfSPZ Vaccine
03
Conditions
Plasmodium falciparum malaria
Beyond the preview
Go deeper on NCT02132299.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02132299.